BiotechTube

Mifepristone tablets

ApprovedTerminated
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Uterine Fibroid

Conditions

Uterine Fibroid

Trial Timeline

Jun 1, 2017 โ†’ Jul 12, 2019

NCT ID
NCT03210324

About Mifepristone tablets

Mifepristone tablets is a approved stage product being developed by China Resources Pharmaceutical Group for Uterine Fibroid. The current trial status is terminated. This product is registered under clinical trial identifier NCT03210324. Target conditions include Uterine Fibroid.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03210324ApprovedTerminated

Competing Products

20 competing products in Uterine Fibroid

See all competitors
ProductCompanyStageHype Score
AzenosertibZentalis PharmaceuticalsPhase 2
44
Amolimogene + AmolimogeneEisaiPhase 2/3
65
Relugolix Combination TabletSumitomo PharmaPhase 3
77
SHR7280 tablets + SHR7280 tablets + PlaceboSHR7280 tablets blank preparationJiangsu Hengrui MedicinePhase 2/3
65
SHR7280 tablets + SHR7280 dry suspensionJiangsu Hengrui MedicinePhase 1
33
Elagolix + 0.5 mg estradiol / 0.1 mg norethindrone acetate + 1 mg estradiol / 0.5 mg norethindrone acetate + E2/NETA placeboAbbViePhase 2
52
Elagolix + Placebo for Estradiol/Norethindrone Acetate + Estradiol/Norethindrone Acetate + Placebo for ElagolixAbbViePhase 3
77
Estradiol/Norethindrone Acetate + ElagolixAbbViePhase 3
77
Elagolix + PlaceboAbbVieApproved
85
Elagolix + Placebo + Estradiol/Norethindrone acetate (E2/NETA) + Estradiol + ProgesteroneAbbViePhase 2
52
Elagolix + Placebo for Estradiol/Norethindrone Acetate + Estradiol/Norethindrone Acetate + Placebo for ElagolixAbbViePhase 3
77
AdavosertibAstraZenecaPhase 2
52
AZD1775AstraZenecaPhase 2
52
Saizenยฎ A + Saizenยฎ BMerckPhase 3
77
Bintrafusp alfaMerckPhase 2
52
Pembrolizumab + LenvatinibMerckPhase 2
52
Pembrolizumab + Placebo for pembrolizumab + CisplatinMerckPhase 3
77
Pembrolizumab (Keytruda)MerckPhase 1
33
Pembrolizumab/Vibostolimab Co-Formulation + Pembrolizumab + Lenvatinib + 5-Fluorouracil + Cisplatin + Paclitaxel + Gemcitabine + Carboplatin + Docetaxel + Bevacizumab + Capecitabine + OxaliplatinMerckPhase 2
52
Zoledronic acidNovartisPhase 2
52

Other Products from China Resources Pharmaceutical Group

Shenfu Zhusheye + 5% glucose injectionApproved
82
Jinfukang oral liquid + Platinum-based doublet chemotherapyApproved
82
Yuxuebi tablet + Placebo tabletApproved
82
Shenfu Injection + 5% Glucose InjectionApproved
82
Qizhi weitong granules(High๏ผ‰ + Qizhi weitong granules(Low๏ผ‰ + PlaceboPhase 2
49